Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA

Clinical Question

Is aspirin as effective as rivaroxaban for prevention of venous thromboembolism (VTE) after total hip or knee arthroplasty?

Bottom line

Extended prophylaxis with low dose aspirin is similar in efficacy to rivaroxaban for the prevention of symptomatic venous thromboembolism (VTE) following total knee or hip arthroplasty. Aspirin is cheap, widely available, and effective, making it a good alternative to the more costly direct oral anticoagulants. 1b

Study design: Randomized controlled trial (double-blinded)

Funding: Government

Setting: Inpatient (any location) with outpatient follow-up

Reviewer

Nita Shrikant Kulkarni, MD
Assistant Professor in Hospital Medicine
Northwestern University
Chicago, IL


Discuss this POEM


Comments

Anonymous

Good info

Anonymous

‘... more costly...’ indeed. Cost online of Bayer Aspirin 81mg @ 100 is $4.19. Cost to me of Xarelto @ 100 for prophylaxis was $363 26 or 86.6 times times more costly

Anonymous

This study needs to be extended for more power to validate the findings by increasing the number of people enrolled into the study.

Anonymous

The orthopods look after the patients after surgery before returning them to my care.

Anonymous

Good poem

Anonymous

Vte prophylaxis

Most vte prophylaxis protocols across Canada are based on the flawed 2008 accp guidelines put out by geertz et al with MAJOR conflicts of interest with the pharm industry, acknowledged in the 2012 guidelines. Accreditation Canada’s “getting started” kit was based on those guidelines, which are clearly wrong. We should all be redoing our protocols based on this poem and the 2012 guidelines to reduce the harm (NNH around 150, NNT in the thousands in the current protocol, and for pe even larger NNT). Worth reading Kotaska et al bjog from feb 2018 for the obstetrical vte story (not a great paper but makes some good points).

Anonymous

Another very expensive drug that was foisted onto doctors while a well known inexpensive drug is just as effective as the newer drug. We wonder why the health care system is in desperate financial crisis. When a very inexpensive well known drug works as well for less than 1% of the cost of the new drug on the market.